Proteomics Market Analysis And Forecast To 2032: By Technology (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, and Others), Application (Diagnostic, Drug Discovery, and Others), End User (Hospitals, Clinical Laboratories, Pharmaceutic

Proteomics Market Analysis And Forecast To 2032: By Technology (Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, and Others), Application (Diagnostic, Drug Discovery, and Others), End User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, Academic Research Laboratories, and Other), And Region

The global Proteomics Market was valued at USD 22.4 Billion in 2022 and it is anticipated to grow up to USD 68.4 Billion by 2032, at a CAGR of 11.8% during the forecast period.

Proteomics is the large-scale study of proteins, including their structure, function, and interactions. Proteins are the main components of cells and play a vital role in all biological processes. By understanding proteins, we can better understand how cells work and how diseases develop. Proteomics research often uses high-throughput techniques to analyze thousands of proteins at once. This allows us to identify patterns and trends that would be difficult to see using traditional methods. Proteomics has been used to discover new proteins, understand the function of existing proteins, and develop new drugs and diagnostic tests.

Global Proteomics Market Scope and Report Structure

Market Trends and Drivers

The rising prevalence of chronic diseases like cancer, Cardiovascular Diseases (CVDs), respiratory diseases, CKD, and others is another factor anticipated to propel the market growth. For instance, according to Globocan, in December 2020, there were 19.3 million new cases of cancer across the world and 10 million cancer-related deaths were reported. Similarly, CVDs are one of the major causes of death worldwide. For instance, as per the WHO (2021), target diseases kill 41 million patients per year. Thus, owing to the increasing prevalence of life-threatening diseases, the demand for personalized therapies is also increasing resulting in a positive impact on the industry.

Market Restraints and Challenges

Proteomics is the large-scale study of proteins, their structures and functions. It is a relatively new field, only coming into its own in the late 1990s with the advent of new technologies that allow for the rapid identification and characterization of proteins.

Despite its promise, proteomics faces a number of key challenges that must be overcome if it is to fulfill its potential. Perhaps the most significant challenge is the sheer size and complexity of the proteome. The human proteome is estimated to contain upwards of 20,000 different proteins, each with its own unique structure and function. Understanding the role of all of these proteins in health and disease is a daunting task.

Another challenge facing proteomics is the lack of standardization. Unlike genomics, which has benefited from years of research and standardization efforts, proteomics is still in its early stages. This lack of standardization makes it difficult to compare results across different studies and to replicate findings.

Finally, proteomics is an expensive field of research. The cost of the necessary equipment and reagents can be prohibitive, making it difficult for many laboratories to get started in proteomics.

Global Proteomics Market Segmental Overview

The report analyses the global Proteomics Market based on product, application, end-user, and region.

Global Proteomics Market by Product

By product, the market is segmented into Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, and Others. Electrophoresis equipment and biochip analyzers are the commonly used instruments for protein analysis. Furthermore, the increasing demand for automation in diagnostic techniques and the need for a cost-effective platform for sample analysishave increased interest among manufacturers to focus on innovations and product development. Moreover, technological breakthroughs (the growing downsizing and integration of biochips as well as advancements in the instruments and workflows for mass spectrometry) in proteomics instruments are expected to drive market trends over the years to come.

Global Proteomics Market by Application

By application, the proteomics market is classified into clinical diagnostics, drug discovery, and other application. The drug discovery segment dominated the global market with a revenue share of over xx% in 2022. On the other hand, the drug discovery segment is estimated to register the fastest growth rate during the projected period. The development of structure-based drug design, a greater emphasis on creating personalized drugs, and more investments in these areas can all be credited for the segment growth. In addition, proteomics technologies also offer a way to show early on in a drug discovery program, saving pharmaceutical corporations a significant amount of capital and eventually benefiting patients as well as the healthcare systems, which contributes to the segment growth.

Global Proteomics Market by End-user

Based on end-user. It is segmented into hospitals, clinical laboratories, pharmaceutical companies, academic research laboratories, and others. Clinical laboratories was the market's dominant segment in 2022. This is due to the widespread use of protein analysis by researchers and clinicians to identify illness biomarkers for early detection and detecting individual risk factors. This is expected to provide new avenues for disease early detection and prevention. It is feasible to discover prospective biomarkers and protein transcriptional regulation that can be used to identify and predict malignancies, as well as evaluate their prognosis, using proteomics-based diagnosis, which promotes the segment's growth.

Geographical Analysis of Global Proteomics Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the industry with the largest revenue share of 45.90% in 2021. This is attributed to the increased investments in the development of structure-based drug design, growth in omics research, demand for high-quality research tools for data reproducibility, and attention to the development of tailored treatments. The expansion of this market is also being aided by the partnerships and collaborations amongmajor companies in this region. For instance, Thermo Fisher Scientific Inc. and Symphogen collaborated to develop verified platform processes for the streamlined characterization and quality monitoring of complex therapeutic proteins.

Major Players in the Global Proteomics Market

The key players in the Proteomics Market are Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation, among others.

COVID-19 Impact:

The impact of COVID-19 was significant owing to the increased research and development activities of pharmaceutical and biotech companies to prepare and manufacture a vaccine, which required biopreservation. For instance, an article published in Stem Cells Translational Medicine Journal stated that the pandemic resulted in the USFDA approving EUA for three mRNA vaccines that Pfizer-BioNTech manufactured in December 2020, Moderna in December 2020, and Janssen in February 2021. The shipping and storage requirements for these vaccines (ultra-cold vs. refrigerated) necessitated bioprocessing methods. Thus, the COVID-19 pandemic is expected to impact the market significantly.

Recent Developments:

• In January 2022, The Proteograph Product Suite’s Broad Commercial Release and the Centers of Excellence program’s debut were both announced by Seer, Inc. The Proteograph Product Suite offers impartial, unmatched access to the proteome. The approach uses unique designed nanoparticles to produce a ground-breaking product that enables quick, thorough, and unbiased proteomics at scale.
• In June 2021, Bruker Corp. launched the two new timsTOF instruments. It enables new methods & applications, such as epiproteomics/PTM characterization, and unbiased, and, deep multi-omic biomarker discovery.

Frequently Asked Questions

Q1.

How big is the Proteomics Market?

Ans.

The global Proteomics Market was valued at USD 22.4 Billion in 2022 and it is anticipated to grow up to USD 68.4 Billion by 2032, at a CAGR of 11.8% during the forecast period.

Q2.

What is the Proteomics Market growth rate?

Ans.

The growth rate of the Proteomics Market is 11.8%

Q3.

Which region holds a major market share for the market?

Ans.

North America holds a major market share of the Proteomics Market in 2022.

Q4.

Which segment accounted for the largest Proteomics Market share?

Ans.

By application, the Regenerative Medicine segment accounted for the largest Proteomics Market share.

Q5.

Who are the key players in the kidney stones management market?

Ans.

The global Proteomics Market report includes players such as Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation, among others.

Q6.

What are the factors driving the Proteomics Market growth?

Ans.

The key drivers of the proteomics market are the increasing demand for personalized medicine, the growing number of proteomics research studies, and the increasing availability of proteomics data.

Q7.

What are the key growth strategies of Proteomics Market players?

Ans.

The key growth strategies of Proteomics Market players are product launch and product approval.

Q8.

Which region will provide more business opportunities for the Proteomics Market during the forecast period?

Ans.

The Asia-Pacific region will provide more business opportunities for the Proteomics Market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.